Plasticity Of Human Microglia And Brain Perivascular Macrophages In Aging And Alzheimer’S Disease

Aging Pathway
Therapeutic
Analytical
Researchers identified distinct types of immune cells in the human brain that undergo adaptive changes during aging and in Alzheimer’s disease, including a specific microglial subtype that expands with disease progression and exhibits increased waste-clearing activity.
Author

Gemini

Published

August 22, 2026

Our brains contain specialized immune cells, called microglia and perivascular macrophages, which are crucial for maintaining brain health and responding to injury or disease. While we know these cells play a significant role in conditions like Alzheimer’s disease, their exact functions and how they change over time have been a mystery.

A groundbreaking study recently delved into these brain immune cells, analyzing over 800,000 cells from more than 1,600 human brains. This extensive research allowed scientists to create a detailed map of these cells, revealing 13 distinct types, or “subtypes,” and how they adapt as we age and as Alzheimer’s disease progresses.

One particularly important discovery was a specific subtype of microglia—the brain’s primary immune cells—that becomes more prevalent in brains affected by Alzheimer’s. This subtype, characterized by a marker called GPNMB, is highly active in “phagocytosis,” which is essentially the cell’s way of engulfing and clearing away cellular debris and waste products. This suggests a protective role for these cells in the disease.

The study also uncovered key regulators of these immune cells. A protein called MITF was found to be essential for maintaining the beneficial state of this waste-clearing microglial subtype. Furthermore, interactions between cells involving proteins like APOE and TREM2 were highlighted as critical pathways influencing how Alzheimer’s disease develops. The protective actions of this specific microglial subtype were shown to depend on TREM2, meaning that if TREM2 is not functioning correctly, these beneficial effects are diminished.

These findings offer crucial insights into the complex world of brain immune cells and their dynamic roles in aging and Alzheimer’s. By understanding these specific cell types and the mechanisms that control them, we are a significant step closer to identifying new targets for therapies that could potentially slow or even prevent the progression of Alzheimer’s disease.


Source: link to paper